Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New CDK8 inhibitors designed for the treatment of colorectal cancer

Nov. 27, 2012

Preclinical assessment of a novel bispecific antibody for the treatment of prostate cancer

Nov. 27, 2012

First-in-human trial of a new class of DNA repair inhibitors

Nov. 27, 2012

Chemokine CXCR7 receptor antagonist CCX-662 tested in glioblastoma model

Nov. 27, 2012

Second germline SUFU mutation linked to Gorlin syndrome

Nov. 27, 2012

Daiichi Sankyo presents in vitro and in vivo data for DS-7423

Nov. 27, 2012

Wnt signaling implicated in alopecia

Nov. 27, 2012

New immunoreactive protein leads to statistically significant decrease in E. muris bacterial load

Nov. 27, 2012

CLSPN gene mutations identified in glioma patients

Nov. 26, 2012

GS-432780-5 and GS-443023-6 show promise in mouse models of chronic liver injury

Nov. 26, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...